Rosales-Aujang E, Muñoz-Enciso JM, Arias-Ulloa R

Language: Spanish
References: 15
Page: 223-228
PDF size: 367.33 Kb.

ABSTRACT

Background: Degenerative diseases are becoming more frequent in adults due to the increase in the average life, among them osteoporosis is with one prevalence higher in women mainly due to the lack of estrogen after menopause.
Objective: Estimate the prevalence of osteoporosis and osteopenia by effectuate a bone densitometry in postmenopausal women and analyze the possible relationship with some recognized risk factors.
Material and methods: Cross-sectional study with 389 patients analyzing the following variables: age; index of body mass and time of treatment with hormone replacement therapy, crossing the information with the result of bone densitometry.
Results: A prevalence rate similar to that reported in our country was obtained. We found that patients with overweight have one higher percentage of osteopenia and osteoporosis than normal weight, which is contrary to what was reported in literature. Also contrary to expectations, untreated patients occupy a higher percentage without bone disorders, while in the leading hormone therapy the lesser percentage was for those whit osteoporosis. We found no differences in terms of age.
Conclusions: Early diagnosis provides an excellent opportunity to address these problems but we must not forget that the best treatment is prevention from an early age.

REFERENCES

1. Linsay R, Cosman F. Osteoporosis. En: Harrison. Principios de Medicina Interna. 17ª ed. Madrid: McGraw-Hill, 2009:2397-2408.

2. American Collage of Obstetricians and Gynecologist. Guidelines for Women’s Health Care. Washington: ACOG, 2002.

3. Instituto Nacional de Estadística y Geografía. Censo de Población 2010.

4. Peck WA, et al. Consensus Development Conference: diagnosis, prophylaxis, and treatment of osteopoprosis. Am J Med 1993;94:646-50.

5. Murillo UA y col. Osteoporosis en la mujer posmenopáusica mexicana. Magnitud del problema. Estudio multicéntrico. Ginecol Obstet Mex 1999;67:227-233.

6. Septién GJM y col. Climaterio femenino. En PAC GO-3. Programa de Actualización Continua en Ginecología y Obstetricia. México: Intersistemas, 2008:1-165.

7. Eunate Arana-Arri y col. Prevalencia de ciertos hábitos determinantes de osteoporosis en mujeres posmenopáusicas del país Vasco. Rev Esp Salud Pública 2001;81:647-656.

8. Yates AJ, Ross PD, Lydick E, Epstein RS. Radiographic absorptiometry in the diagnosis of osteoporosis. Am J Med 1995;98:41S-47S.

9. Genant HK, et al. Universal Standardization for dual X ray absorptiometry: Patient and Phantom Cross-Calibration Results. J Bone Min Res 1994;9:1503-1514.

10. Mendoza RMA y col. Osteoporosis en mexicanas mayores de 40 años. Rev Med IMSS 2003; 41:193-202.

11. Clark P, et al. The prevalence of radiographic vertebral fractures en Latin American countries: The Latin American Vertebral Osteoporosis Study (LAVOS). Osteoporos Int 2009;20:275-282.

12. Reyes BJ, Moreno OJ. Prevalencia de osteopenia y osteoporosis en mujeres posmenopáusicas. Aten Primaria 2005;37:342-347.

13. Rivera MVC, Halabe ChJ. Actualidades en terapia hormonal estrogénica y osteoporosis posmenopáusica. Med Int Mex 2005;21:431-9.

14. Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321-333.

15. Recommendations for estrogen and progestogen use in peri and postmenopausal women: October 2004 position statement of The North American Menopause Society. Menopause 2004;11:589-600.